Will stem cells from fat and growth factors from blood bring new hope to female patients with reproductive disorders?

Female Humans Infertility, Female / therapy Regenerative Medicine Stem Cell Transplantation Stem Cells / classification
Growth factors Platelet-based treatment Regenerative medicine Reproductive disorders Stromal vascular fraction

Journal

Reproductive biology
ISSN: 2300-732X
Titre abrégé: Reprod Biol
Pays: Poland
ID NLM: 101160559

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 22 08 2020
revised: 21 11 2020
accepted: 06 12 2020
pubmed: 28 2 2021
medline: 15 12 2021
entrez: 27 2 2021
Statut: ppublish

Résumé

Female reproductive system disorders (FRSD) with or without infertility are prevalent women's health problems with a variety of treatment approaches including surgery and hormone therapy. It currently considering to sub-branch of regenerative medicine including stem cells or growth factors injection-based delivery treatment might be improved female reproductive health life. The most common products used for these patients treatment are autologous cell or platelet-based products from patients, including platelet-rich plasma, plasma rich in growth factor, platelet-rich fibrin, and stromal vascular fraction. In this review, we discuss each of the above products used in treatment of FRSD and critically evaluate the clinical outcome.

Identifiants

DOI: 10.1016/j.repbio.2020.100472 PMID: 33639342
pubmed: 33639342
pii: S1642-431X(20)30302-8
doi: 10.1016/j.repbio.2020.100472
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100472

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors report no declarations of interest.

Auteurs

Amir Valizadeh (A)

Stem Cell Research Center, Stem Cells and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Samira Asghari (S)

Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Sepideh Bastani (S)

Stem Cell Research Center, Stem Cells and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.

Raana Sarvari (R)

Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Neda Keyhanvar (N)

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; Gene Yakhteh Keyhan (Genik) Company (Ltd), Pharmaceutical Biotechnology Incubator, Tabriz University of Medical Sciences, Tabriz, Iran; ARTAN1100 Startup Accelerator, Tabriz, Iran.

Sepideh Jalilzadeh Razin (SJ)

Stem Cell Research Center, Stem Cells and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.

Alireza Yousefzadeh Khiabani (AY)

Department of Epidemiology and Reproductive Health, Reproductive Epidemiology Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.

Bahman Yousefi (B)

Department of Clinical Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Mehdi Yousefi (M)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Alireza Shoae-Hassani (A)

Stem Cell and Regenerative Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran; Andam Baft Yakhteh (ABY) Company (Ltd), Tehran, Iran.

Ata Mahmoodpoor (A)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Hamed Hamishehkar (H)

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Shima Tavakol (S)

Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.

Saeed Heidari Keshel (SH)

Medical Nanotechnology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Tissue Engineering and Applied Cell Science, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mohammad Nouri (M)

Stem Cell Research Center, Stem Cells and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran; ARTAN1100 Startup Accelerator, Tabriz, Iran; Zist Andam Yakhteh Azerbaijan (ZAYA) Company (PHT), Medical Instrument Technology Incubator, Tabriz University of Medical Sciences, Tabriz, Iran.

Alexander Marcus Seifalian (AM)

Nanotechnology and Regenerative Medicine Commercialization Centre (Ltd), The London Innovation Bio Science Centre, London NW1 0NH, United Kingdom.

Peyman Keyhanvar (P)

Stem Cell Research Center, Stem Cells and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran; ARTAN1100 Startup Accelerator, Tabriz, Iran; Zist Andam Yakhteh Azerbaijan (ZAYA) Company (PHT), Medical Instrument Technology Incubator, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran; HealthNBICS Group, Convergence of Knowledge and Technology to the benefit of Society Network (CKTSN), Universal Scientific Education and Research Network (USERN), Tabriz, Iran. Electronic address: Keyhanvarp@tbzmed.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Will stem cells from fat and growth factors...
questionsmedicales.fr › Maladies urogénitales › Maladies génitales › Infertilité › Infertilité féminine › Will stem cells from fat and growth factors...
questionsmedicales.fr › Professions de santé › Médecine › Médecine régénérative › Will stem cells from fat and growth factors...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation cellulaire › Transplantation de cellules souches › Will stem cells from fat and growth factors...
questionsmedicales.fr › Cellules › Cellules souches › Will stem cells from fat and growth factors...